EXPERIENCE WITH HAEMONETICS CELL SAVER 5+ IN OBSTERIC PRACTICE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To define the possibilities and benefits of intraoperative autoerythrocyte reinfusion (IAR) using a Haemonetics Cell Saver 5+ in massive obstetric hemorrhage and to assess IAR versus donor red blood cell transfusion. Subject and methods. One hundred and forty-nine histories of surgical deliveries accompanied by a hemorrhage volume of ≥ 2000 ml (≥ 30% of circulating blood volume) were retrospectively analyzed. The deliveries were performed at the Center for Family Planning and Reproduction, Moscow Healthcare Department, and the Moscow Perinatal Medical Center in 1997 to 2013. Group 1 consisted of 44 patients who had been transfused donor red blood cells to make up for blood loss. The other 105 puerperas had undergone IAR using a Haemonetics Cell Saver 5+. Out of them, 49 women needed additional donor red blood cell transfusion. These patients formed Group 2. Blood loss was replenished with only autoerythrocytes in 56 patients included into Group 3. Results. In Group 3 patients, infusion therapy involved a lower volume of fresh frozen plasma (p<0.0001); the duration of treatment in an intensive care unit was shortest and occasionally more than 23 hours (p<0.0001); the patients were discharged from hospital generally at 8 days postpartum (p<0.0001). These puerperas demonstrated the highest hemoglobin levels at all study time intervals (in intraoperative hemorrhage (p<0.00001), after 6 hours later (p<0.05), at days 2 (p<0.05) and 7(p<0.0001) after sustaining blood loss). Although in Group 2 the blood loss volume exceeded that in Group 1 (p<0.0001), Group 2 puerperas had higher hemoglobin levels intraoperatively, after 6 hours, and days 2 and 7 days postpartum than Group 1 ones (p<0.05). Conclusion. IAR is effective and safe in obstetric hemorrhage, can reduce the volume of transfused donor red blood cells and the duration of inpatient treatment in puerperas with sustained massive blood loss. Autoerythrocyte reinfusion using a Cell Saver may be recommended for the wide introduction into obstetric practice.

Full Text

Restricted Access

About the authors

G. M SAVELYEVA

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

M. A KURTSER

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

Email: cfp@list.ru

I. Yu BRESLAV

Perinatal Medical Center

Email: irina_breslav@mail.ru

L. E BREUSENKO

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia

O. A LATYSHKEVICH

Center for Family Planning and Reproduction, Moscow Healthcare Department

Email: latishkevich2003@mail.ru

A. M SHABNITSKY

Center for Family Planning and Reproduction, Moscow Healthcare Department

References

  1. Saving Mothers’ Lives. Reviewing maternal deaths to make motherhood safer: 2006-2008. Centre for Maternal and Child Enquiries (CMACE). Br. J. Obstet. Gynaecol. 118(Suppl.1): 1-203.
  2. Catling S. Blood conservation techniques in obstetrics: a UK perspective. Int. J. Obstet. Anesth. 2007; 16: 241-9.
  3. Marik P.E., Corwin H.L. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit. Care Med. 2008; 36: 2667-74.
  4. Kuppurao L., Wee M. Perioperative cell salvage. Contin. Educ. Anaesth. Crit. Care Pain. 2010; 10(4): 104-8.
  5. Fong J., Gurewitsch E., Kang H., Kump L., Mack P.F. An analysis of transfusion practice and the role of intraoperative red blood cell salvage during cesarean delivery. Anesth. Analg. 2007; 104(3): 666-72.
  6. Allam J., Cox M., Yentis S.M. Cell salvage in obstetrics. Int. J. Obstet. Anesth. 2007; 17: 37-45.
  7. Blundell J. Experiments on the transfusion of blood by the syringe. Med. Chir. Trans. 1818; 9(1): 56-92.
  8. Blundell J. Observation on transfusion of blood. With a description of his gravitator. Lancet. 1828; 2: 321-6.
  9. Kasper S.M., Kasper A.S. History of autologous blood transfusion in the 19th century. Zentralbl. Chir. 1996; 121(3): 250-7.
  10. Grimes D.A. A simplified device for intraoperative autotransfusion. Obstet. Gynecol. 1988; 72: 947-50.
  11. National Institute for Health and Clinical Excellence. Interventional Procedure Consultation Document. Intraoperative blood cell salvage in obstetrics. 2005, March.
  12. National Institute for Health and Clinical Excellence. Interventional procedure guidance. IPG 144 intraoperative blood cell salvage in obstetrics. 2005, November.
  13. Royal College of Obstetricians and Gynaecologists. Blood transfusion in obstetrics. London: Royal College of Obstetricians and Gynaecologists (RCOG); 2007 December (Green-top guideline, no. 47).
  14. Royal College of Obstetricians and Gynaecologists. Placenta praevia, placenta praevia accreta and vasa praevia: diagnosis and management. London: Royal College of Obstetricians and Gynaecologists (RCOG); 2011 Jan. 26 p. (Green-top guideline, no. 27).
  15. ACOG. Committee on Obstetric Practice. Committee opinion no. 529: placenta. Obstet. Gynecol. 2012; 120(1): 207-11.
  16. American Congress of Obstetricians & Gynecologists (ACOG). District II, series 2, October 2012.
  17. Esper S.A., Waters J.H. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus. 2011; 9: 139-47.
  18. Waters J.H., Biscotti C., Potter P.S. Amniotic fluid removal during cell salvage in the caesarean section patient. Anesthesiology. 2000; 92: 1519-22.
  19. McDonnell N.J., Kennedy D., Long L.J., Gallagher-Swann M.C., Paech M.J. The development and implementation of an obstetric cell salvage service. Anaesth. Intensive Care. 2010; 38(3): 492-9.
  20. Liumbruno G.M., Liumbruno C., Rafanelli D. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion. 2011; 51: 2244-56.
  21. Рогачевский О.В. Современные технологии кровосбережения в акушерстве: Дис.. д-ра мед. наук. М.; 2007.
  22. Нунаева Э.С. Интраоперационная реинфузия крови при операции кесарева сечения: Дис.. канд. мед. наук. М.; 1997.
  23. Федорова Т.А., Рогачевский О.В., Василенко И.А., Данилов А.Ю., Джабраилова Д.А., Артемов Д.В., Сухенко Е.П. Интраоперационная реинфузия аутоэритроцитов и показатели морфофункционального состояния эритроцитов у женщин при миомэктомии. Акушерство и гинекология. 2013; 5: 58-65.
  24. Абубакирова А.М., Баранов И.И., Мурашко Л.Е. и др. Лечебная эффективность программ аутоплазмодонорства при кровопотере кесарева сечения с расширением объема операции. В кн.: Материалы 7-й конференции Московского общества гемафереза. М.; 1999: 15.
  25. Федорова Т.А., Рогачевский О.В., Василенко И.А. и др. Интраоперационная реинфузия аутоэритроцитов и показатели морфофункционального состояния эритроцитов у женщин при миомэктомии. Акушерство и гинекология. 2013; 5: 58-65.
  26. Malik S., Brooks H., Singhal T. Cell saver in obstetrics. J. Obstet. Gynaecol. 2010; 30(8): 826-8.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies